Loading
A phase 2/3 trial testing Varegacestat in desmoid tumour, active and no longer recruiting.
A Study of AL102 in Patients With Progressing Desmoid Tumours is a phase 2/3 interventional study registered as NCT04871282, led by Immunome, and active but no longer recruiting on the registry. Official title: RINGSIDE: A Phase 2/3, Randomised, Multicenter Study to Evaluate AL102 in Patients With Progressing Desmoid Tumours. Planned enrolment is 198 participants (actual). The study started in 2021-09-01 and primary completion is expected in 2025-12-03. No results have been posted on ClinicalTrials.gov.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Immunome, Desmoid tumour.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/